The PDECX model 1T0327 with overexpression of both EGFR and FGFR1 protein showed only modest tumor growth inhibition to theliatinib treatment suggesting that FGFR1 overexpression could diminish theliatinib efficacy. Here, FGFR1 is linked to neoplasm.